Opportunity

Federal Register #2026-19423

OFAC General License 2 for Congo Sanctions: Medical and Agricultural Transactions Authorized

Buyer

Office of Foreign Assets Control

Posted

September 23, 2026

Identifier

2026-19423

NAICS

541690, 541720, 541380

This notice from the Department of the Treasury's Office of Foreign Assets Control (OFAC) announces the publication of General License 2 under the Democratic Republic of the Congo Sanctions Regulations. - Government Buyer: - Department of the Treasury - Office of Foreign Assets Control (OFAC) - Key Details: - General License 2 authorizes certain transactions otherwise prohibited by sanctions regulations - Covered activities include: - Exportation or reexportation of agricultural commodities - Exportation or reexportation of medicine and medical devices - Replacement parts and components for medical devices - Software updates for medical devices - Conduct of clinical trials and medical research activities involving the Democratic Republic of the Congo or the Republic of Rwanda - Transactions necessary for medical care and operation of medical clinics or facilities - No specific OEMs, vendors, products, or purchase quantities are mentioned - This is not a procurement or award notice; no bids or proposals are requested - Notable Requirement: - License covers activities related to medical and agricultural support in sanctioned regions

Description

The Department of the Treasury's Office of Foreign Assets Control (OFAC) is publishing General License 2 issued pursuant to the Democratic Republic of the Congo Sanctions Regulations. This general license authorizes transactions related to agricultural commodities, medicine, medical devices, replacement parts and components, software updates, or clinical trials involving the Democratic Republic of the Congo or the Republic of Rwanda. The license was issued on July 10, 2026, and was previously made available on OFAC's website. It includes authorizations for transactions ordinarily incident and necessary to the exportation or reexportation of specified items and the conduct of medical research activities in the affected countries.

View original listing